Research notes

The report flags a Wipro futures sell idea (27th Oct expiry) at CMP 157, citing a range breakdown and lower top-lower bottom structure.

The technical conviction delivery idea recommends buying Sambhv Steel Tubes at CMP ₹162 with SL ₹156 and target ₹174 over a 1-week duration, citing a pole and flag breakout.

The Focus Investment Ideas list shows Syrma SGS Tech. rated Buy at CMP 1688 with a target of 2,000 (18% upside).

The Focus Investment Ideas list shows Emcure Pharma rated Buy at CMP 1972 with a target of 2,300 (17% upside).

The Focus Investment Ideas list shows Eternal rated Buy at CMP 328 with a target of 430 (31% upside).

The Focus Investment Ideas list shows Adani Ports rated Buy at CMP 1770 with a target of 2,130 (20% upside).

The Focus Investment Ideas list shows SPR Auto Technologies rated Buy at CMP 4776 with a target of 6,150 (29% upside).

The Velocity Idea section recommends BUY on Divi's Laboratories at CMP ₹9,540 with SL ₹8,870 and target ₹10,800, citing peptide API demand growth from oral Wegovy and tariff clarity under US Proclamation 11020.

The report initiates coverage on Torrent Power with a Neutral rating at CMP INR 1220, describing its generation, transmission and distribution business and RE expansion plans, while noting a 'View: Positive' comment despite the Neutral rating label.

The report takes a Positive view on Navin Fluorine at CMP INR 8234, citing commissioning of its Dahej debottlenecking project and continuation of anti-dumping duty on HFC blends, with expected FY26-28 CAGR of 26%/25%/26% in revenue/EBITDA/PAT.

The report rates Endurance Technologies BUY with CMP INR 2655 and target INR 3350 (26% upside), citing its subsidiary's full acquisition of Stöferle entities and expected margin expansion from 2QFY27.

The report notes the promoter will sell a 6.6% stake via block deal at ₹2,150/share for ~₹922 crore.

The report mentions an investor is likely to sell 15 lakh shares (~0.8% stake) via block deal at a floor price of ₹2,990/share for ~₹450 crore.

The report notes Coal India signed a non-binding MoU with HURL to evaluate a coal-gasification-based urea project at Sindri, Jharkhand, with a positive view.

The report says a subsidiary has commissioned its Chlorination & Specialty Chemicals plant in Gujarat with cumulative capex of ~₹300 crore, with a positive view.

The report states Solar Industries has incorporated Solar Explochem in Botswana with a 65% stake, marking entry into Botswana's explosives market, with a positive view.

The report notes CPP Investments will invest up to ₹3,000 crore for ~27% stake in Prestige Hospitality Ventures, with a positive view.

The note reports Sebi dropped minimum public shareholding and fraud allegations against Vinod Adani and 11 other noticees, finding no proof he controlled the offshore funds.

The note mentions Glenmark Pharma gained following the US tariff exemption news for pharma products.

The note mentions IPCA Laboratories gained following the US tariff exemption news for pharma products.

The note mentions Sun Pharma gained following the US tariff exemption news for pharma products.

The note mentions Dr. Reddy's gained after the US exempted India from tariffs on certain pharma products, and lists it among stocks with a positive derivative setup.

The note mentions Mankind Pharma gained alongside other pharma stocks after the US granted tariff exemptions on speciality drugs.

The note reports H.G. Infra received a Letter of Financial Closure from NHAI for a Rs 1,582 crore road project in Odisha.

The note states Symbiotec Pharmalab received a US FDA Establishment Inspection Report classifying its Pithampur facility under Voluntary Action Indicated (VAI) status.